Diabetes research and clinical practice
Diabetes research and clinical practice are rapidly evolving, revealing many new therapeutic targets. Among these, incretion-based therapies such as GLP-1 incretions and GLP-1 and DPP4, as well as oral therapies such as insulin secretagogues, are promising. Additionally, advances in the field include new developments such as the regeneration and expansion of pancreatic islet cells and the treatment of microbial infections. Technologies such as embryonic stem cell and fatal precursor cell transplantation and stem cell therapy have also emerged as effective methods in the treatment of diabetes. In addition to these new treatments, Chinese medicine also plays an important role in diabetes treatment.